D
David Norman
Researcher at Umeå University
Publications - 6
Citations - 565
David Norman is an academic researcher from Umeå University. The author has contributed to research in topics: Performance status & Prostate cancer. The author has an hindex of 5, co-authored 5 publications receiving 303 citations.
Papers
More filters
Journal ArticleDOI
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Anders Widmark,Adalsteinn Gunnlaugsson,Lars Beckman,Camilla Thellenberg-Karlsson,Morten Høyer,Magnus Lagerlund,Jon Kindblom,Claes Ginman,Bengt Johansson,Kirsten Björnlinger,Mihajl Seke,Måns Agrup,Per Fransson,Björn Tavelin,David Norman,Björn Zackrisson,Harald Anderson,Elisabeth Kjellén,Lars Franzén,Per Nilsson +19 more
TL;DR: There was weak evidence of an increased frequency of acute physician-reported RTOG grade 2 or worse urinary toxicity in the ultra-hypofractionation group at end of radiotherapy, consistent with the physician-evaluated toxicity.
Journal ArticleDOI
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
Per Fransson,Per Nilsson,Adalsteinn Gunnlaugsson,Lars Beckman,Björn Tavelin,David Norman,Camilla Thellenberg-Karlsson,Morten Høyer,Magnus Lagerlund,Jon Kindblom,Claes Ginman,Bengt Johansson,Kirsten Björnlinger,Mihajl Seke,Måns Agrup,Björn Zackrisson,Elisabeth Kjellén,Lars Franzén,Anders Widmark +18 more
TL;DR: The HYPO-RT-PC trial as mentioned in this paper compared conventional fractionation and ultra-hypofractionation up to 6 years after treatment in patients with localised prostate cancer, and the results showed that UHF was non-inferior to traditional fractionation regarding 5-year failure-free survival and toxicity.
Journal ArticleDOI
Ultrahypofractionation for prostate cancer : Outcome from the Scandinavian phase 3 HYPO-RT-PC trial
Anders Widmark,Adalsteinn Gunnlaugsson,Lars Beckman,Camilla Thellenberg-Karlsson,Morten Høyer,Magnus Lagerlund,Per Fransson,Björn Tavelin,David Norman,Jon Kindblom,Claes Ginman,Bengt Johansson,Mihalj Seke,K. Bjorlinger,Måns Agrup,Elisabeth Kjellén,Lars Franzén,Peter M. Nilsson +17 more
TL;DR: Ultrahypofractionation for prostate cancer : Outcome from the Scandinavian phase 3 HYPO-RT-PC trial shows promising results in women and promising results for men.
Journal ArticleDOI
The clinical presentation of acute bacterial meningitis varies with age, sex and duration of illness.
TL;DR: This Swedish study reviewed differences in clinical presentation and laboratory findings of acute bacterial meningitis in children aged one month to 17 years in Västerbotten County, Sweden.
Journal ArticleDOI
Sustained reductions of invasive infectious disease following general infant Haemophilus influenzae type b and pneumococcal vaccination in a Swedish Arctic region.
TL;DR: The effects of general infant Hib and pneumococcal vaccinations on invasive infectious diseases among children and the need of meningococcal vaccination are evaluated in a Swedish Arctic region.